Clinical trial
The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)
NCT05897047 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 15, 2023
- Completion date
- July 30, 2026
- Enrollment
- 391 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant failure, kidney transplant rejection